Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.46 - $5.2 $25,451 - $53,799
-10,346 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$4.16 - $9.08 $10,703 - $23,362
-2,573 Reduced 19.92%
10,346 $49,000
Q4 2021

Feb 15, 2022

SELL
$7.65 - $11.38 $117,090 - $174,182
-15,306 Reduced 54.23%
12,919 $110,000
Q3 2021

Nov 15, 2021

SELL
$9.93 - $13.59 $48,766 - $66,740
-4,911 Reduced 14.82%
28,225 $328,000
Q2 2021

Aug 16, 2021

SELL
$11.87 - $15.96 $45,153 - $60,711
-3,804 Reduced 10.3%
33,136 $416,000
Q1 2021

May 18, 2021

BUY
$13.87 - $21.04 $207,620 - $314,947
14,969 Added 68.13%
36,940 $512,000
Q3 2020

Nov 17, 2020

BUY
$19.3 - $26.92 $424,040 - $591,459
21,971 New
21,971 $502,000

About Akouos, Inc.


  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.